JESSICA HOWIE: Open Payments
NPI 1932677473 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,826 in 177 payments from 18 companies in 2025. Trend: 2023 $4,547 · 2024 $7,095 · 2025 $5,826
Food & beverage: $3,539Consulting: $1,705Travel & lodging: $381Education: $201
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 29 | $2,568 |
| Arcutis Biotherapeutics, Inc. | 6 | $404 |
| ABBVIE INC. | 24 | $357 |
| Galderma Laboratories, L.P. | 11 | $353 |
| Janssen Biotech, Inc. | 23 | $322 |
| GENZYME CORPORATION | 12 | $273 |
| Novartis Pharmaceuticals Corporation | 4 | $228 |
| UCB, Inc. | 10 | $205 |
| Incyte Corporation | 12 | $196 |
| LNHC, Inc | 8 | $184 |
Products named: Sotyktu, DUPIXENT, NEMLUVIO, Zoryve, TREMFYA, Bimzelx, RINVOQ, OPZELURA.
Industry payments across MA — which companies pay providers there.
